Bellerophon Completes Enrollment in Cohort 2 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

August 1, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search